These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 37358415

  • 1. Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in ERG2 as a Major Mechanism Conferring Reduced Susceptibility to Amphotericin B in Candida kefyr.
    Asadzadeh M, Alfouzan W, Parker JE, Meis JF, Kelly SL, Joseph L, Ahmad S.
    Microbiol Spectr; 2023 Aug 17; 11(4):e0147423. PubMed ID: 37358415
    [Abstract] [Full Text] [Related]

  • 2. ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait.
    Ahmad S, Joseph L, Parker JE, Asadzadeh M, Kelly SL, Meis JF, Khan Z.
    Antimicrob Agents Chemother; 2019 Feb 17; 63(2):. PubMed ID: 30455247
    [Abstract] [Full Text] [Related]

  • 3. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
    Hull CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL.
    Antimicrob Agents Chemother; 2012 Aug 17; 56(8):4223-32. PubMed ID: 22615281
    [Abstract] [Full Text] [Related]

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 17; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 5. Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity.
    Ahmad S, Khan Z, Al-Sweih N, Alfouzan W, Joseph L, Asadzadeh M.
    PLoS One; 2020 Nov 17; 15(10):e0240426. PubMed ID: 33108361
    [Abstract] [Full Text] [Related]

  • 6. Loss-of-Function ROX1 Mutations Suppress the Fluconazole Susceptibility of upc2AΔ Mutation in Candida glabrata, Implicating Additional Positive Regulators of Ergosterol Biosynthesis.
    Ollinger TL, Vu B, Murante D, Parker JE, Simonicova L, Doorley L, Stamnes MA, Kelly SL, Rogers PD, Moye-Rowley WS, Krysan DJ.
    mSphere; 2021 Dec 22; 6(6):e0083021. PubMed ID: 34935446
    [Abstract] [Full Text] [Related]

  • 7. Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
    Rybak JM, Dickens CM, Parker JE, Caudle KE, Manigaba K, Whaley SG, Nishimoto AT, Luna-Tapia A, Roy S, Zhang Q, Barker KS, Palmer GE, Sutter TR, Homayouni R, Wiederhold NP, Kelly SL, Rogers PD.
    Antimicrob Agents Chemother; 2017 Sep 22; 61(9):. PubMed ID: 28630186
    [Abstract] [Full Text] [Related]

  • 8. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.
    Young LY, Hull CM, Heitman J.
    Antimicrob Agents Chemother; 2003 Sep 22; 47(9):2717-24. PubMed ID: 12936965
    [Abstract] [Full Text] [Related]

  • 9. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH.
    Dan Med J; 2016 Oct 22; 63(10):. PubMed ID: 27697142
    [Abstract] [Full Text] [Related]

  • 10. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, Manai M, Sanglard D.
    Antimicrob Agents Chemother; 2013 Jul 22; 57(7):3182-93. PubMed ID: 23629718
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Etest and MICRONAUT-AM Assay for Antifungal Susceptibility Testing of Candida auris: Underestimation of Fluconazole Resistance by MICRONAUT-AM and Overestimation of Amphotericin B Resistance by Etest.
    Asadzadeh M, Ahmad S, Alfouzan W, Al-Obaid I, Spruijtenburg B, Meijer EFJ, Meis JF, Mokaddas E.
    Antibiotics (Basel); 2024 Sep 04; 13(9):. PubMed ID: 39335013
    [Abstract] [Full Text] [Related]

  • 12. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC.
    J Antimicrob Chemother; 2015 Sep 04; 70(9):2551-5. PubMed ID: 26017038
    [Abstract] [Full Text] [Related]

  • 13. Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae.
    Kannan A, Asner SA, Trachsel E, Kelly S, Parker J, Sanglard D.
    mBio; 2019 Dec 24; 10(6):. PubMed ID: 31874914
    [Abstract] [Full Text] [Related]

  • 14. Investigation of the Defective Growth Pattern and Multidrug Resistance in a Clinical Isolate of Candida glabrata Using Whole-Genome Sequencing and Computational Biology Applications.
    Merdan O, Şişman AS, Aksoy SA, Kızıl S, Tüzemen NÜ, Yılmaz E, Ener B.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0077622. PubMed ID: 35867406
    [Abstract] [Full Text] [Related]

  • 15. [In vitro amphotericin B susceptibility of korean bloodstream yeast isolates assessed by the CLSI broth microdilution method, Etest, and Minimum fungicidal concentration test].
    Park JY, Shin JH, Uh Y, Kim EC, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW.
    Korean J Lab Med; 2008 Oct 31; 28(5):346-52. PubMed ID: 18971615
    [Abstract] [Full Text] [Related]

  • 16. Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China.
    Tian S, Rong C, Li H, Wu Y, Wu N, Chu Y, Jiang N, Zhang J, Shang H.
    Emerg Microbes Infect; 2024 Dec 31; 13(1):2398596. PubMed ID: 39234778
    [Abstract] [Full Text] [Related]

  • 17. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.
    Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J.
    Antimicrob Agents Chemother; 2003 Aug 31; 47(8):2404-12. PubMed ID: 12878497
    [Abstract] [Full Text] [Related]

  • 18. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
    Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J, Barbuch R, Bard M, Rogers PD.
    J Antimicrob Chemother; 2004 Aug 31; 54(2):376-85. PubMed ID: 15201233
    [Abstract] [Full Text] [Related]

  • 19. Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation.
    Siopi M, Peroukidou I, Beredaki MI, Spruijtenburg B, de Groot T, Meis JF, Vrioni G, Tsakris A, Pournaras S, Meletiadis J.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0443122. PubMed ID: 37036351
    [Abstract] [Full Text] [Related]

  • 20. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D.
    Med Mycol; 1998 Jun 15; 36 Suppl 1():119-28. PubMed ID: 9988500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.